New and effective method to develop primary hepatocytes from liver cancer patients

Exp Biol Med (Maywood). 2022 Jun;247(11):972-981. doi: 10.1177/15353702221085534. Epub 2022 Apr 26.

Abstract

Liver cancer (LC) is one of the most common malignant tumors worldwide. Since the mechanism of LC pathogenesis and metastasis cannot be carried out directly on the human body, it is particularly important to establish human liver cancer cell lines for research in vitro. In this study, tissue block adherence method combined with cell clumps digestion method was used to establish primary human hepatocytes (PHHs) with a successful rate of 60% (45/75). Short tandem repeat (STR) analysis proved the cells were derived from its paired tissues. These cells from hepatocellular carcinoma (HCC) expressed NTCP and secreted ALB and AAT as detected by western blot, and expressed hepatocyte-specific membrane protein ASGR1 as detected by flow cytometry. Liver cancer biomarkers like CK7 in ICC (intrahepatic cholangiocarcinoma), AFP, and GPC3 in HCC expressed of different degree as detected by immunohistochemical analysis. These cells displayed typical liver cancer cell morphological characteristics and can passage stably. In conclusion, we developed an effective method to establish PHHs. Further studies are necessary to study if these cells maintaining other liver function and reproduce the physiology of the tumors and how these cells behavior in the drug development.

Keywords: 2D culture technologies; Liver cell culture; primary human hepatocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asialoglycoprotein Receptor / metabolism
  • Bile Duct Neoplasms* / metabolism
  • Bile Duct Neoplasms* / pathology
  • Bile Ducts, Intrahepatic / pathology
  • Biomarkers, Tumor / metabolism
  • Carcinoma, Hepatocellular* / pathology
  • Cholangiocarcinoma* / metabolism
  • Cholangiocarcinoma* / pathology
  • Glypicans / metabolism
  • Hepatocytes / metabolism
  • Humans
  • Liver Neoplasms* / pathology

Substances

  • ASGR1 protein, human
  • Asialoglycoprotein Receptor
  • Biomarkers, Tumor
  • GPC3 protein, human
  • Glypicans